slides · global inventory
Evidence
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 40,452
Current window 15,961-15,990
Pages 1,349
Rows per page 30
Beat
15,961-15,990 of 40,452
15
Includes QoQ growth and year-over-year growth metrics for key financial line items.Houlihan Lokey | Investment Banking Pitch Book | 34 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
16
The table includes a peer group of dairy companies and compares them against Synutra International Inc. at current and offer prices.Houlihan Lokey | Investment Banking Pitch Book | 34 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
17
This is a standard disclosure/methodology slide for a valuation or financial analysis section.Houlihan Lokey | Investment Banking Pitch Book | 34 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
18
Includes annotations regarding periods where Synutra's EBITDA was negative or non-meaningful.Houlihan Lokey | Investment Banking Pitch Book | 34 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
19
The slide includes a detailed footnote section explaining the adjustments made to arrive at the per share equity value.Houlihan Lokey | Investment Banking Pitch Book | 34 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
20
The slide includes a disclaimer box and detailed footnotes regarding the DCF assumptions.Houlihan Lokey | Investment Banking Pitch Book | 34 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
21
Includes a summary row for Mean, Median, High, and Low values at the bottom of the main data set.Houlihan Lokey | Investment Banking Pitch Book | 34 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
22
Houlihan Lokey | Investment Banking Pitch Book | 34 slidesHoulihan Lokey | Investment Banking Pitch Book | 34 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
23
Houlihan Lokey | Investment Banking Pitch Book | 34 slidesHoulihan Lokey | Investment Banking Pitch Book | 34 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
24
The slide presents 8 distinct tables comparing various dairy and infant formula companies.Houlihan Lokey | Investment Banking Pitch Book | 34 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
13
The chart shows two diverging growth trajectories, with the Wall Street Consensus consistently higher than the Orlando Management case.Moelis & Company | Investment Banking Pitch Book | 24 slides · Moelis & Company
Consulting deck Investment bank Beat · Evidence & ProofLoop · Hypothesis Test1 hit
14
Moelis & Company | Investment Banking Pitch Book | 24 slidesMoelis & Company | Investment Banking Pitch Book | 24 slides · Moelis & Company
Consulting deck Investment bank Beat · Evidence & ProofLoop · Hypothesis Test1 hit
15
Includes valuation bridge (Equity Value to Enterprise Value) and multiple sensitivity analysis.Moelis & Company | Investment Banking Pitch Book | 24 slides · Moelis & Company
Consulting deck Investment bank Beat · Evidence & ProofLoop · Hypothesis Test1 hit
16
The table includes metrics like Enterprise Value, Revenue, Growth, Margins, and EV/Revenue and EV/EBITDA multiples for CY'16 and CY'17.Moelis & Company | Investment Banking Pitch Book | 24 slides · Moelis & Company
Consulting deck Investment bank Beat · Evidence & Proof1 hit
17
Includes a comparison row for 'Napa' against the transaction set averages and medians.Moelis & Company | Investment Banking Pitch Book | 24 slides · Moelis & Company
Consulting deck Investment bank Beat · Evidence & Proof1 hit
18
Includes Moelis & Company branding; page number 17.Moelis & Company | Investment Banking Pitch Book | 24 slides · Moelis & Company
Consulting deck Investment bank Beat · Evidence & Proof1 hit
19
Includes operational update and specific caveats regarding the relevance of current projections due to performance deterioration.Morgan Stanley | Investment Banking Pitch Book | 33 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
20
Project Roosevelt, Morgan Stanley, confidential exhibit.Morgan Stanley | Investment Banking Pitch Book | 33 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
21
Confidential exhibit marked with [*]. Includes market check and operational updates alongside detailed DCF and valuation tables.Morgan Stanley | Investment Banking Pitch Book | 33 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
22
Includes detailed assumptions regarding IRS Section 382 limitations and WACC calculation methodology.Morgan Stanley | Investment Banking Pitch Book | 33 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
23
Includes detailed footnotes regarding JV interests, EBITDA calculations, pipeline PV, NOL assumptions, and preferred dividends.Morgan Stanley | Investment Banking Pitch Book | 33 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
24
Starwood is excluded from the Tier 1 average, min, and max calculations due to its pending merger with Marriott.Morgan Stanley | Investment Banking Pitch Book | 33 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
25
Includes detailed adjustments for debt, preferred stock, and share dilution.Morgan Stanley | Investment Banking Pitch Book | 33 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
26
Includes specific methodology notes for WACC components and capital structure.Morgan Stanley | Investment Banking Pitch Book | 33 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
27
Includes detailed assumptions on discount rates, exit multiples, and debt/equity adjustments.Morgan Stanley | Investment Banking Pitch Book | 33 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
28
Includes assumptions regarding PIK equity, cost of equity, and exit multiples.Morgan Stanley | Investment Banking Pitch Book | 33 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
29
Includes specific valuation assumptions like discount rates, exit multiples, and NOL values for each methodology.Morgan Stanley | Investment Banking Pitch Book | 33 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
03
PJT Partners slide detailing deal terms, ownership splits, and leverage ratios (EBITDA multiples) pre/post synergies.PJT Partners | Investment Banking Pitch Book | 8 slides · PJT Partners
Consulting deck Investment bank Beat · Evidence & Proof1 hit
04
The slide uses color-coded borders to distinguish between different EBITDA scenarios (base vs. synergy-adjusted).PJT Partners | Investment Banking Pitch Book | 8 slides · PJT Partners
Consulting deck Investment bank Beat · Evidence & ProofLoop · Benchmark Gap1 hit
05
Includes $500mm Post-Transaction Rights Offer; synergies include $35mm cost and $60mm tax.PJT Partners | Investment Banking Pitch Book | 8 slides · PJT Partners
Consulting deck Investment bank Beat · Evidence & Proof1 hit